Activation of NF-B upregulates snail and consequent repression of E-cadherin in cholangiocarcinoma cell invasion

Hepato-Gastroenterology

Volumn 58, Issue 105, 2011, Pages 1-7

  Zhang, Kejun ^a   Zhao, Jie ^a   Liu, Xiaoyi ^a   Yan, Bomin ^a   Chen, Dong ^a   Gao, Yuan ^a   Hu, Xiao ^a   Liu, Shisong ^a   Zhang, Dianliang ^a   Zhou, Changying ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; E cadherin; Invasion; Nuclear factor kappa B (NF kB); Snail

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR SNAIL; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BLOTTING, WESTERN; CADHERINS; CELL MOVEMENT; CHOLANGIOCARCINOMA; NEOPLASM INVASIVENESS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 79954993059     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM: Biliary tract cancers. N Engl J Med 1999;341:1368-78.
2. Malouf G, Dreyer C, Guedj N, Paradis V, Degos F, Belghiti J, Le Tourneau C, Faivre S, Raymond E: Prognosis factors of cholangiocarcinoma: contribution of recent molecular biology tools.Bull Cancer. 2009;96:405-15.
3. Sarkar FH, Li Y, Wang Z, Kong D: NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol. 2008;27:293-319.
4. Min C, Eddy SF, Sherr DH, Sonenshein GE: NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem. 2008;104:733-44. (Pubitemid 351830825)
5. Sawanyawisuth K: Genes and cholangiocarcinoma. Southeast Asian J Trop Med Public Health. 2009; 40:701-12.
6. Wu Y, Zhou BP: Snail: More than EMT. Cell Adh Migr. 2010;4:1423-1431.
7. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, et al: Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.Oncogene.2007;26:7445-56.
8. Tanimura Y, Kokuryo T, Tsunoda N, Yamazaki Y, Oda K, Nimura Y, Naing Mon N, Huang P, Nakanuma Y, Chen MF, Jan YY et al: Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2.Cancer Lett. 2005; 219:205-13.
9. Friedrichsen S, Harper CV, Semprini S, Wilding M, Adamson AD, Spiller DG, Nelson G, Mullins JJ, White MR, Davis JR: Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling. Endocrinology. 2006;147:773-81.
10. Wegener E, Krappmann D: Dynamic protein complexes regulate NF-kappaB signaling.Handb Exp Pharmacol. 2008;186:237-59.
11. Vanden Berghe W, Vermeulen L, Delerive P, De Bosscher K, Staels B, Haegeman G: A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv Exp Med Biol. 2003; 544:181-96.
12. Piette J, Piret B, Bonizzi G, Schoonbroodt S et al: Multiple redox regulation in NF-kappaB transcription factor activation.Biol Chem. 1997;378:1237-45.
13. Nourani S, Haber G: Cholangiopancreatoscopy: a comprehensive review. Gastrointest Endosc Clin N Am. 2009; 19:527-43.
14. Tonini G, Virzi V, Fratto ME, Vincenzi B, Santini D: Targeted therapy in biliary tract cancer: 2009 update. Future Oncol. 2009; 5:1675-84.
15. Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease.J Cell Biol. 2006; 172:973-81.
16. Fukase K, Ohtsuka H, Onogawa T, Oshio H, Ii T, Mutoh M, Katayose Y, et al: Bile acids repress E-cadherin through the induction of Snail and increase cancer invasiveness in human hepatobiliary carcinoma.Cancer Sci. 2008;99:1785-92.
17. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer.Development. 2005;132: 3151-3161.
18. Nieto MA: The snail superfamily of zinc-finger transcription factors.Nat Rev Mol Cell Biol .2002;3: 155-166.
19. Baritaki S, Chapman A, Yeung K, Spandidos DA, Palladino M, Bonavida B: Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.Oncogene. 2009;28:3573-85.
20. Strippoli R, Benedicto I, Pérez Lozano ML, Cerezo A, López-Cabrera M, del Pozo MA: Epithelial-to-mesenchymal transition of peritoneal mesothelial cells is regulated by an ERK/NF-kappaB/Snail1 pathway.Dis Model Mech. 2008; 1:264-74.
21. Dong R, Wang Q, He XL, Chu YK, Lu JG, Ma QJ: Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells.Braz J Med Biol Res. 2007;40:1071-8. (Pubitemid 47232861)
22. Zhang C, Carl TF, Trudeau ED, Simmet T, Klymkowsky MW: An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm.PLoS One. 2006; 27:1-6.
23. Barbera MJ, Puig I, Dominguez D, Julien-Grille S, Guaita-Esteruelas S et al: Regulation of Snail transcription during epithelial to mesenchymaltransition of tumor cells. Oncogene . 2004;23: 7345-7354. (Pubitemid 39382137)
24. Wu K, Bonavida B: The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol. 2009;29:241-54.
25. Katsman A, Umezawa K, Bonavida B: Chemosensitization and immunosensitization of resistant cancer cells to apoptosis and inhibition of metastasis by the specific NF-kappaB inhibitor DHMEQ. Curr Pharm Des. 2009; 15: 792-808.
26. Iwatsuki M, Mimori K, Yokobori T, Ishi H, Beppu T, Nakamori S, Baba H, Mori M: Epithelial-mesenchymal transition in cancer development and its clinical significance.Cancer Sci. 2010;101:293-9.
27. van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W: Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol. 2009;5:1169-79.
28. Micalizzi DS, Ford HL: Epithelial-mesenchymal transition in development and cancer.Future Oncol. 2009;5(8):1129-43.
29. Gos M, Miłoszewska J, Przybyszewska M: Epithelial-mesenchymal transition in cancer progression.Postepy Biochem. 2009;55:121-8.
30. Tsuji T, Ibaragi S, Hu GF: Epithelial-mesenchymal transition and cell cooperativity in metastasis.Cancer Res. 2009;69:7135-9.
31. Natalwala A, Spychal R, Tselepis C: Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.World J Gastroenterol. 2008; 14:3792-7.
32. Guarino M: Epithelial-mesenchymal transition and tumour invasion.Int J Biochem Cell Biol. 2007; 39:2153-60.
33. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression.J Cell Physiol. 2007;213:374-83.
34. Bagnato A, Rosanò L: Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.Cells Tissues Organs. 2007;185:85-94.